Efficacy of Nanodropper-mediated Topical Anesthetic
NCT06636708
Corneal Diseases, Effectiveness of Microdrops
New York, United States
View Trial DetailsNCT Number: NCT00396188
The purpose of this study is to determine the ability of a proprietary software screening tool to discriminate normal corneas (front surface of the eye) from previously diagnosed corneal conditions (diseases/surgeries/pathologies) and to determine the repeatabiltity and reproducibility of the Atlas II corneal topographer in normal human corneas.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Shiley Eye Center-University of California San Diego, La Jolla, California, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Normals
Keratoconus
Myopic Laser Vision Correction
Patients who have undergone myopic:
Hyperopic Laser Vision Correction
Patients who have undergone hyperopic:
Orthokeratology
Exclusion criteria
Time frame: 1-2 hours
Time frame: 1-2 hours
Carl Zeiss Meditec, Inc.
Industry
Corneal Analysis - Pathology Detection Aid
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06636708
Corneal Diseases, Effectiveness of Microdrops
New York, United States
View Trial DetailsNCT07132437
Corneal Diseases, Eye Diseases
Beijing, China
View Trial DetailsNCT04421300
Conjunctival Diseases, Conjunctivitis
Guangzhou, Guangdong, China
View Trial DetailsNCT02348242
Corneal Diseases, Corneal Injuries
Paris, Île-de-France Region, France
View Trial Details